Biomarkers by Oxford Global will explore the essential criteria for validating clinical biomarkers, shedding light on the steps and challenges involved.

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.

In the quest to improve diagnostics, new technologies are key, but so is overcoming entrenched bias.

Researchers have used an artificial intelligence model to analyse the metabolites of patients with or without ovarian cancer and have reported shocking accuracy of diagnosis.

Digital biomarkers, collected from wearables and apps, are reshaping patient-centered healthcare with real-time insights and personalized care. Challenges like data privacy and interoperability require collaboration between healthcare, tech, and regulators for full integration.

Advancements in biosensors, notably graphene-based ones, show promise in swiftly identifying elusive lung cancer biomarkers, potentially revolutionising early diagnosis.

Here, we speak to Matthias von Herrath about Biomarkers US 2023 and some current trends in the industry concerning research and technological development.

Here, we speak to UT Southwestern’s Shuang Liang about monitoring TREM2 as a non-invasive diagnostic biomarker for NASH.

Concise and insightful summaries of presentations delivered by prominent thought leaders at Biomarkers 2023.